$AIG Headlines Security risks get wealthy families’

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$AIG Headlines

Security risks get wealthy families’ attention 6:03 a.m. Dec. 22, 2014 - Liz Moyer
As TARP era winds down, U.S.’s financial-crisis bailout scorecard nears completion 12:56 p.m. Dec. 20, 2014 - Ryan Tracy
Why MetLife is called systemically important by the government 12:30 p.m. Dec. 19, 2014 - Eric Garcia
Ally Financial exits TARP as Treasury sells remaining stake 11:56 a.m. Dec. 19, 2014 - Julie Steinberg
The Fed has forgotten that banks caused the Great Recession 9:25 a.m. Dec. 19, 2014 - David Weidner
MetLife designated as ‘systemically important’ by U.S. panel 5:24 p.m. Dec. 18, 2014 - Leslie Scism
7 big ways to invest your money in 2015 4:05 a.m. Dec. 18, 2014 - Jeff Reeves
Sherrod Brown to be top Democrat on Banking Committee 4:08 p.m. Dec. 12, 2014 - Eric Garcia
Which stocks the billionaires are buying — and selling 1:32 p.m. Dec. 12, 2014 - The Trading Deck
Fed governor says central bank limited in promoting financial stability 4:32 p.m. Dec. 3, 2014 - Eric Garcia
Was China ready to bail out AIG? 8:58 a.m. Nov. 26, 2014 - Leslie Scism
Federal Reserve proposes new rules for GE Capital 4:08 p.m. Nov. 25, 2014 - MarketWatch.com
FSOC criticized for lack of transparency 5:08 p.m. Nov. 20, 2014 - Eric Garcia
Hedge fund titan Dan Loeb reports Alibaba stake, dumps AIG 5:31 p.m. Nov. 14, 2014 - MarketWatch
Future of Dodd-Frank uncertain with Republican majority 3:57 p.m. Nov. 5, 2014 - Eric Garcia
Alibaba, Priceline, Herbalife in focus Tuesday 12:01 a.m. Nov. 4, 2014 - MarketWatch
Herbalife shares drop after hours as earnings disappoint 6:57 p.m. Nov. 3, 2014 - MarketWatch
Updates, advisories and surprises 6:01 p.m. Nov. 3, 2014 - MarketWatch
U.S. stocks end choppy session lower 4:27 p.m. Nov. 3, 2014 - Barbara Kollmeyer
AIG reports a rise in profit and premiums written, increases stock buyback plan 4:25 p.m. Nov. 3, 2014 - Tomi Kilgore


Hedge Fund Clustering 41 min ago - Seeking Alpha
AIG Scales a New 52-Week High on Positive Tidings - Analyst Blog 3:15 p.m. Dec. 31, 2014 - Zacks.com
Meadowbrook to be Acquired by Fosun for $433 Million - Analyst Blog 1:20 p.m. Dec. 31, 2014 - Zacks.com
Is it Time to Add FBL Financial (FFG) to Your Portfolio? - Analyst Blog 12:20 p.m. Dec. 31, 2014 - Zacks.com
FBL Financial (FFG) Hits 52-Week High on Rating Upgrade - Analyst Blog 11:35 a.m. Dec. 31, 2014 - Zacks.com
Top 10 Stocks For 2015 9:13 a.m. Dec. 29, 2014 - Seeking Alpha
Strong Rebound In Third Quarter 2014 Buybacks 6:40 a.m. Dec. 29, 2014 - Seeking Alpha
First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases in Value by 35% 5:21 p.m. Dec. 26, 2014 - GuruFocus.com
AIG Debt Safe; CAT Loss & Macro Qualms Hit Core Growth - Analyst Blog 2:50 p.m. Dec. 24, 2014 - Zacks.com
The Hartford's Divestitures, Capital Deployment Look Good - Analyst Blog 1:40 p.m. Dec. 23, 2014 - Zacks.com
Insurers Seen Keeping Dividend Yield Near 2% 7:59 a.m. Dec. 23, 2014 - Barrons.com
American International Group Inc. (AIG): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Dec. 23, 2014 - Zacks.com
Seeing the Forest 3:45 a.m. Dec. 20, 2014 - Barrons.com
Bailouts Approach Final Reckoning 7:07 p.m. Dec. 19, 2014 - The Wall Street Journal Interactive Edition
MetLife Vote Wasn’t Unanimous 6:56 p.m. Dec. 19, 2014 - The Wall Street Journal Interactive Edition
MetLife Tagged as SIFI: What it Means for Your Portfolio? - Analyst Blog 2:50 p.m. Dec. 19, 2014 - Zacks.com
Today's Market: Japan And Earnings Moving These Stocks 9:24 a.m. Dec. 19, 2014 - Seeking Alpha
7 Biggest Investment Opportunities of 2015 7:47 a.m. Dec. 19, 2014 - InvestorPlace.com
MetLife Considers Challenging ‘Systemically Important’ Label 9:16 p.m. Dec. 18, 2014 - The Wall Street Journal Interactive Edition
Why American International Group (AIG) Could Beat Earnings Estimates Again - Tale of the Tape 8:40 a.m. Dec. 17, 2014 - Zacks.com


AIG Completes the Acquisition of Ageas Protect, Leading Provider of Life Protection Products 1:45 a.m. Jan. 5, 2015 - BusinessWire - BZX
AIG Announces AG Platinum Choice VUL 9:01 a.m. Dec. 15, 2014 - BusinessWire - BZX
Dow to Add New Independent Directors to Its Board 8:45 a.m. Nov. 21, 2014 - BusinessWire - BZX
The Securities Arbitration Law Firm of Klayman & Toskes Investigates LPL Financial and VALIC Financial Advisors Relating to the Supervision of Jodie Linn Miller and the Sale of Tri-Med Corporation Notes 4:19 p.m. Nov. 20, 2014 - BusinessWire - BZX
Insurance Equities Technical Commentary - American Intl., Hartford Financial Services, Genworth Financial, The Progressive, and Old Republic Intl. 9:00 a.m. Nov. 19, 2014 - PR Newswire - PRF
AIG Names Rhodri Williams Vice President, Communications and Public Affairs for Europe, Middle East, and Africa 9:31 a.m. Nov. 17, 2014 - BusinessWire - BZX
AIG Appoints Charlie Shamieh CEO Life, Health, and Disability Insurance; Alessa Quane Named Corporate Chief Actuary 4:31 p.m. Nov. 13, 2014 - BusinessWire - BZX
AIG Introduces Polaris Select InvestorSM—A New Variable Annuity with a Deep and Broad Investment Platform 12:01 p.m. Nov. 11, 2014 - BusinessWire - BZX
Jeffrey S. Bagnell Named in Super Lawyers' Top 50 Connecticut Lawyers 9:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Upcoming Conference Presentation, and Dividend Declaration - Research Reports on MasterCard, AIG, Morgan Stanley, Capital One and MetLife 9:10 a.m. Nov. 10, 2014 - PR Newswire - PRF
AIG Board of Directors Authorizes Repurchase of Additional Shares of AIG Common Stock, Declares Common Stock Dividend 4:10 p.m. Nov. 3, 2014 - BusinessWire - BZX
Award, Launch of New Payments Solution, Market Activity, Advisory Update, and Dividend Declaration - Research Reports on AIG, MasterCard, Morgan Stanley, BNY Mellon and MetLife 8:30 a.m. Oct. 31, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Earnings Schedules, Dividend Declaration, and New Product Launch - Research Reports on Morgan Stanley, AIG, Tanger, MasterCard and BB&T 7:55 a.m. Oct. 22, 2014 - PR Newswire - PRF
Increase in Liability Limits, Financing, Survey Results, Expansion and Property Portfolio Expansion - Research Reports on AIG, MetLife, Morgan Stanley, MasterCard and Franklin Resources 8:25 a.m. Oct. 14, 2014 - PR Newswire - PRF
Stock Watchout on Insurance Industry - MetLife, Prudential Financial, Lincoln National, American Intl. Group, and Hartford Financial Services 7:40 a.m. Oct. 10, 2014 - PR Newswire - PRF
A.M. Best Withdraws Ratings of Chartis Excess Limited 10:17 a.m. Oct. 9, 2014 - BusinessWire - BZX
AIG Provides Expanded $1 Billion Casualty Capacity for North American Rail Companies 8:01 a.m. Oct. 9, 2014 - BusinessWire - BZX
AIG to Report Third Quarter 2014 Results on November 3, 2014 3:15 p.m. Oct. 6, 2014 - BusinessWire - BZX
Businesses Seek To Minimize The Effects Of Disaster Through Sustainability 12:55 p.m. Oct. 6, 2014 - PR Newswire - PRF
Notes Redemption, New Index Launch, Grants, Welfare Initiative, and Study Results - Research Reports on AIG, MasterCard, MetLife, Morgan Stanley and BlackRock 8:15 a.m. Oct. 2, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading